ImmuCell Corp (ICCC)
5.235
+0.12
(+2.45%)
USD |
NASDAQ |
May 08, 15:47
ImmuCell Debt to Equity Ratio: 0.4789 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.4789 |
| September 30, 2023 | 0.4734 |
| June 30, 2023 | 0.3996 |
| March 31, 2023 | 0.3899 |
| December 31, 2022 | 0.3368 |
| September 30, 2022 | 0.3276 |
| June 30, 2022 | 0.3264 |
| March 31, 2022 | 0.3274 |
| December 31, 2021 | 0.2805 |
| September 30, 2021 | 0.2875 |
| June 30, 2021 | 0.2827 |
| March 31, 2021 | 0.3341 |
| December 31, 2020 | 0.336 |
| September 30, 2020 | 0.3468 |
| June 30, 2020 | 0.3486 |
| March 31, 2020 | 0.2953 |
| December 31, 2019 | 0.2905 |
| September 30, 2019 | 0.2958 |
| June 30, 2019 | 0.2984 |
| March 31, 2019 | 0.2994 |
| December 31, 2018 | 0.4491 |
| September 30, 2018 | 0.418 |
| June 30, 2018 | 0.3997 |
| March 31, 2018 | 0.391 |
| December 31, 2017 | 0.3796 |
| Date | Value |
|---|---|
| September 30, 2017 | 0.2802 |
| June 30, 2017 | 0.2091 |
| March 31, 2017 | 0.1603 |
| December 31, 2016 | 0.1527 |
| September 30, 2016 | 0.1856 |
| June 30, 2016 | 0.1886 |
| March 31, 2016 | 0.1909 |
| December 31, 2015 | 0.3002 |
| September 30, 2015 | 0.3165 |
| June 30, 2015 | 0.0806 |
| March 31, 2015 | 0.087 |
| December 31, 2014 | 0.0968 |
| September 30, 2014 | 0.1036 |
| June 30, 2014 | 0.109 |
| March 31, 2014 | 0.1107 |
| December 31, 2013 | 0.1156 |
| September 30, 2013 | 0.1191 |
| June 30, 2013 | 0.1248 |
| March 31, 2013 | 0.13 |
| December 31, 2012 | 0.1379 |
| September 30, 2012 | 0.1427 |
| June 30, 2012 | 0.1464 |
| March 31, 2012 | 0.1512 |
| December 31, 2011 | 0.1597 |
| September 30, 2011 | 0.1649 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.2805
Minimum
Dec 2021
0.4789
Maximum
Dec 2023
0.3398
Average
0.3276
Median
Sep 2022
Debt to Equity Ratio Benchmarks
| NovaBay Pharmaceuticals Inc | 0.3431 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 43.81M |
| Total Liabilities (Quarterly) | 18.82M |
| Shareholders Equity (Quarterly) | 24.99M |
| Current Ratio | 2.733 |
| Net Debt Paydown Yield | -0.76% |